Monsuller, Eusebio .
HRN: 28-26-25 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2025
CEFUROXIME 750MG (VIAL)
12/12/2025
12/18/2025
IV
480mg
Q8
PCAP B, UTI
Checking Final Appropriateness
12/12/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
12/12/2025
12/19/2025
PO
7ml
TID
Amoebiasis
Checking Final Appropriateness
12/14/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/14/2025
12/20/2025
IV
145mg
Q8
Intestinal Amoebiasis
Checking Final Appropriateness